Sarah Bly

Sarah Bly is Director of Regulatory Science, Strategy and Innovation at Worldwide Clinical Trials. Based in the UK with over 19 years’ experience in the pharmaceutical industry.  Sarah is a lead in providing high level strategic regulatory strategies, risk assessments and solutions including driving health equity strategies.  Sarah is also an active volunteer and stakeholder for initiatives such as EU-X-CT which aims to improve cross-border access to clinical trials for patients in the EU.